Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Association Between Suggestive Symptom of Restless Legs Syndrome and COVID-19 Vaccination: A Pilot StudyAssociation Between Suggestive Symptom of Restless Legs Syndrome and COVID-19 Vaccination: A Pilot Study

Other Titles
Association Between Suggestive Symptom of Restless Legs Syndrome and COVID-19 Vaccination: A Pilot Study
Authors
석진명나은진김슬기박종규박은경SONGPAMELA양광익
Issue Date
Apr-2022
Publisher
대한수면연구학회
Keywords
COVID-19 vaccines; Restless legs syndrome; Adverse effects; Mass vaccination.
Citation
Journal of sleep medicine, v.19, no.1, pp 6 - 11
Pages
6
Journal Title
Journal of sleep medicine
Volume
19
Number
1
Start Page
6
End Page
11
URI
https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/20710
DOI
10.13078/jsm.210022
ISSN
2384-2423
2384-2431
Abstract
Objectives: Various sensory symptoms have been recognized after COVID-19 vaccination. Here, we aimed to explore the association between the suggestive symptom of restless legs syndrome (RLSss) and COVID-19 vaccination using an online survey.Methods: We prospectively studied participants who were working in our hospital after at least the first dose of the ChAdOx1 or BNT162b2 mRNA vaccine. The participants were invited via smartphone messages and voluntarily filled out an online questionnaire that included adverse events after vaccination. We considered the participants as having RLSss if they reported that they had three or more symptoms in the restless legs syndrome (RLS) diagnostic criteria.Results: A total of 628 participants (506 female; mean age, 37.7±12.4 years) responded fully to our online survey. 588 participants (93.6%) received the first dose of the ChAdOx1 vaccine (BNT162b2 mRNA vaccine for 40 participants). A total of 44 out of the 628 participants (7.0%) reported that they had RLSss. Myalgia was more common in participants with RLSss than in those without RLSss (97.7% vs. 67.3%, p<0.001). Multivariate testing showed that age (odds ratio, 1.037 per 1 year increase; 95% CI, 1.004–1.071) and the presence of myalgia (odds ratio, 20.479; 95% CI, 4.266–368.206) were associated with the presence of RLSss.Conclusions: This pilot study explored RLSss after COVID-19 vaccination and the results suggested that RLS might be one of the causes of adverse symptoms after COVID-19 vaccination. Further studies are required to confirm the relationship between RLS and COVID-19 vaccination.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Neurology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Seok, Jin Myoung photo

Seok, Jin Myoung
College of Medicine (Department of Neurology)
Read more

Altmetrics

Total Views & Downloads

BROWSE